ANDA 70522, held by Abraxis Pharm. Aminocaproic Acid.
As of Nov 15, 2026, ANDA 70522 (Aminocaproic Acid), held by Abraxis Pharm, was first approved by FDA on Jun 17, 1986, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 17, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Aminocaproic Acid250MG/ML ยท injectable;injection | Aminocaproic Acid | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
